First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece
Stavroula Aristeidou
First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece
Sofia Xirou
First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece
Panagiotis Ferentinos
Second Department of Psychiatry, Attikon General University Hospital, School of Medicine, National and Kapodistrian University of Athens, 124 62 Athens, Greece
Ioannis Evdokimidis
First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece
Michail Rentzos
First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece
Ioannis Seimenis
Medical Physics Laboratory, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece
Background: Magnetic resonance spectroscopy (MRS) in amyotrophic lateral sclerosis (ALS) has been overwhelmingly applied to motor regions to date and our understanding of frontotemporal metabolic signatures is relatively limited. The association between metabolic alterations and cognitive performance in also poorly characterised. Material and Methods: In a multimodal, prospective pilot study, the structural, metabolic, and diffusivity profile of the hippocampus was systematically evaluated in patients with ALS. Patients underwent careful clinical and neurocognitive assessments. All patients were non-demented and exhibited normal memory performance. 1H-MRS spectra of the right and left hippocampi were acquired at 3.0T to determine the concentration of a panel of metabolites. The imaging protocol also included high-resolution T1-weighted structural imaging for subsequent hippocampal grey matter (GM) analyses and diffusion tensor imaging (DTI) for the tractographic evaluation of the integrity of the hippocampal perforant pathway zone (PPZ). Results: ALS patients exhibited higher hippocampal tNAA, tNAA/tCr and tCho bilaterally, despite the absence of volumetric and PPZ diffusivity differences between the two groups. Furthermore, superior memory performance was associated with higher hippocampal tNAA/tCr bilaterally. Both longer symptom duration and greater functional disability correlated with higher tCho levels. Conclusion: Hippocampal 1H-MRS may not only contribute to a better academic understanding of extra-motor disease burden in ALS, but given its sensitive correlations with validated clinical metrics, it may serve as practical biomarker for future clinical and clinical trial applications. Neuroimaging protocols in ALS should incorporate MRS in addition to standard structural, functional, and diffusion sequences.
